These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34948221)

  • 1. Role of Organic Cation Transporter 3 and Plasma Membrane Monoamine Transporter in the Rewarding Properties and Locomotor Sensitizing Effects of Amphetamine in Male andFemale Mice.
    Clauss NJ; Koek W; Daws LC
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.
    Fraser-Spears R; Krause-Heuer AM; Basiouny M; Mayer FP; Manishimwe R; Wyatt NA; Dobrowolski JC; Roberts MP; Greguric I; Kumar N; Koek W; Sitte HH; Callaghan PD; Fraser BH; Daws LC
    Eur J Pharmacol; 2019 Jan; 842():351-364. PubMed ID: 30473490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unsuspected role for organic cation transporter 3 in the actions of amphetamine.
    Mayer FP; Schmid D; Owens WA; Gould GG; Apuschkin M; Kudlacek O; Salzer I; Boehm S; Chiba P; Williams PH; Wu HH; Gether U; Koek W; Daws LC; Sitte HH
    Neuropsychopharmacology; 2018 Nov; 43(12):2408-2417. PubMed ID: 29773909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.
    Takahashi N; Miner LL; Sora I; Ujike H; Revay RS; Kostic V; Jackson-Lewis V; Przedborski S; Uhl GR
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9938-43. PubMed ID: 9275230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faster Serotonin Clearance in CA3 Region of Hippocampus and Antidepressant-like Effect of Decynium-22 in Juvenile Mice Are Putatively Linked to Increased Plasma Membrane Monoamine Transporter Function: Implications for Efficacy of Antidepressants in Juveniles.
    Bowman MA; Gomez JA; Mitchell NC; Wells AM; Vitela M; Clarke KM; Horton RE; Koek W; Daws LC
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene.
    Duan H; Wang J
    J Biol Chem; 2013 Feb; 288(5):3535-44. PubMed ID: 23255610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering Functional Contributions of PMAT (
    Beaver JN; Weber BL; Ford MT; Anello AE; Kassis SK; Gilman TL
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
    Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
    Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine Clearance Through Polyspecific Transporters in the Brain.
    Yoshikawa T; Yanai K
    Handb Exp Pharmacol; 2017; 241():173-187. PubMed ID: 27679412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms of Amphetamines.
    Reith MEA; Gnegy ME
    Handb Exp Pharmacol; 2020; 258():265-297. PubMed ID: 31286212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
    Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
    Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.
    Gross JD; Kaski SW; Schroer AB; Wix KA; Siderovski DP; Setola V
    J Psychopharmacol; 2018 Feb; 32(2):191-203. PubMed ID: 29364035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interaction of Organic Cation Transporters 1-3 and PMAT with Psychoactive Substances.
    Maier J; Niello M; Rudin D; Daws LC; Sitte HH
    Handb Exp Pharmacol; 2021; 266():199-214. PubMed ID: 33993413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
    Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
    Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
    Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH
    Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of exocytotic transmitter release by decynium-22 through an inhibition of ion channels.
    Haar G; Hrachova K; Wagner T; Boehm S; Schicker K
    Front Pharmacol; 2023; 14():1276100. PubMed ID: 37881182
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain Plasma Membrane Monoamine Transporter in Health and Disease.
    Vieira LS; Wang J
    Handb Exp Pharmacol; 2021; 266():253-280. PubMed ID: 33751232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors.
    Duan H; Hu T; Foti RS; Pan Y; Swaan PW; Wang J
    Drug Metab Dispos; 2015 Nov; 43(11):1773-80. PubMed ID: 26285765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
    Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens.
    David HN; Dhilly M; Degoulet M; Poisnel G; Meckler C; Vallée N; Blatteau JÉ; Risso JJ; Lemaire M; Debruyne D; Abraini JH
    Transl Psychiatry; 2015 Jul; 5(7):e594. PubMed ID: 26151922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.